Report #2837330

Received Apr 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: TX
Recovered: Unknown
Vaccinated: Mar 28, 2025
Onset: Mar 28, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	1	X006982	—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE/PQC; HCP called and reported inadvertent administration of expired VARIVAX to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Limited patient demographics were provided The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-Mar-2025, the patient was inadvertently administration a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) lot# X006982 and expiration date reported as and upon internal review confirmed as 07-Mar-2025 (dose, route of administration and vaccination site were not reported) administered for prophylaxis (expired product administered). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT). No additional adverse event (AE) and no product quality complaint (PQC) was noted (no adverse event).

Other medications

Sterile diluent